Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes J Vicencio, C Sánchez-Bolaños, I Moreno-Sánchez, D Brena, CE Vejnar, ... Nature Communications 13 (1), 2601, 2022 | 29 | 2022 |
Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin FJ García-Rodríguez, C Martínez-Fernández, D Brena, D Kukhtar, ... Disease models & mechanisms 11 (6), dmm033506, 2018 | 23 | 2018 |
CRISPR editing of sftb-1/SF3B1 in Caenorhabditis elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical … X Serrat, D Kukhtar, E Cornes, A Esteve-Codina, H Benlloch, G Cecere, ... PLoS Genetics 15 (10), e1008464, 2019 | 20 | 2019 |
Ancestral function of Inhibitors-of-kappaB regulates Caenorhabditis elegans development D Brena, J Bertran, M Porta-De-La-Riva, Y Guillén, E Cornes, D Kukhtar, ... Scientific reports 10 (1), 16153, 2020 | 13 | 2020 |
Mimicking of splicing-related retinitis pigmentosa mutations in C. elegans allow drug screens and identification of disease modifiers D Kukhtar, K Rubio-Peña, X Serrat, J Cerón Human Molecular Genetics 29 (5), 756-765, 2020 | 12 | 2020 |
Fluorizoline-induced apoptosis requires prohibitins in nematodes and human cells J Saura-Esteller, I Sanchez-Vera, S Nunez-Vazquez, ... Apoptosis 26, 83-95, 2021 | 7 | 2021 |
Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles SY Srinivasan, PA Illera, D Kukhtar, N Benseny-Cases, J Cerón, J Álvarez, ... ACS nano 17 (17), 17273-17284, 2023 | 2 | 2023 |
Synthetic biology in multicellular organisms: Opportunities in nematodes D Kukhtar, M Fussenegger Biotechnology and Bioengineering 120 (8), 2056-2071, 2023 | 2 | 2023 |